We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Kraft Heinz
KHC
$32.4B
| $10.9M | 0.04% |
122,093
-959
| -0.8% | -$84.9K |
|
|
ONC
277
BeOne Medicines Ltd
ONC
$34.1B
| $10.8M | 0.04% |
351,348
+238,604
| +212% | +$6.93M |
|
|
FDIQ
278
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$52.5M
| $10.8M | 0.04% |
246,980
-260
| -0.1% | -$11K |
|
279
Erie Indemnity
ERIE
$12.5B
| $10.5M | 0.04% |
102,797
-2,756
| -3% | -$274K |
|
|
CMD
280
DELISTED
Cantel Medical Corporation
CMD
| $10.5M | 0.04% |
134,452
-11,838
| -8% | -$859K |
|
|
MRSH
281
Marsh
MRSH
$90.4B
| $10.3M | 0.04% |
153,905
+6,628
| +5% | +$444K |
|
282
McCormick & Company Non-Voting
MKC
$13.9B
| $10.3M | 0.04% |
206,014
+5,932
| +3% | +$301K |
|
283
Marriott International
MAR
$99.6B
| $10.3M | 0.04% |
152,632
+18,131
| +13% | +$1.28M |
|
284
WEX
WEX
$6.21B
| $10.3M | 0.04% |
94,995
+7,980
| +9% | +$781K |
|
|
285
Fastenal
FAST
$55.9B
| $9.79M | 0.03% |
937,660
-27,806,488
| -97% | -$296M |
|
|
DEA
286
Easterly Government Properties
DEA
$1.17B
| $9.71M | 0.03% |
203,571
+5,524
| +3% | +$272K |
|
287
United Parcel Service
UPS
$90.6B
| $9.64M | 0.03% |
88,159
+1,215
| +1% | +$133K |
|
288
Markel Group
MKL
$25.6B
| $9.64M | 0.03% |
10,378
+460
| +5% | +$429K |
|
289
Cato Corp
CATO
$63.7M
| $9.53M | 0.03% |
289,593
-351,277
| -55% | -$12.2M |
|
|
KMG
290
DELISTED
KMG Chemicals Inc
KMG
| $9.49M | 0.03% |
335,063
+1,187
| +0.4% | +$32.8K |
|
|
PX
291
DELISTED
Praxair Inc
PX
| $9.29M | 0.03% |
76,840
-3,360
| -4% | -$398K |
|
292
Triumph Financial Inc
TFIN
$1.8B
| $9.18M | 0.03% |
462,603
+4,106
| +0.9% | +$74.4K |
|
293
Church & Dwight Co
CHD
$23.9B
| $8.77M | 0.03% |
183,062
-1,714
| -0.9% | -$84.6K |
|
294
Baxter International
BAX
$12.6B
| $8.65M | 0.03% |
181,763
+2,381
| +1% | +$112K |
|
295
Coherus Oncology
CHRS
$224M
| $8.65M | 0.03% |
322,902
+25,152
| +8% | +$686K |
|
296
LKQ Corp
LKQ
$6.93B
| $8.64M | 0.03% |
243,738
+32,124
| +15% | +$1.11M |
|
297
Honeywell
HON
$79.2B
| $8.63M | 0.03% |
82,360
+1,365
| +2% | +$143K |
|
298
Northern Trust
NTRS
$22.2B
| $8.54M | 0.03% |
125,542
+4,860
| +4% | +$330K |
|
299
Walmart Inc
WMT
$915B
| $8.51M | 0.03% |
353,937
+15,669
| +5% | +$380K |
|
300
Chubb
CB
$141B
| $8.51M | 0.03% |
67,702
+2,286
| +3% | +$290K |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.